You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Meridian Bioscience's Illumigene C. difficile test; Nanosphere's Verigene SP respiratory virus panel; Veredus Laboratories' VereFlu test and VereID Biosystem; and IMDx's 2009 influenza H1N1 assay
The C. difficile test is the first molecular diagnostic product for Meridian. It hopes to market the test later this year.
Kettering Health Network hopes to cut costs by using Diatherix's PCR-based infectious disease tests.
British, French, and American researchers reported that they have sequenced and compared different strains of Clostridium difficile in an attempt to find genetic causes for the bug's increased virulence.
Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.
23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.
The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.
In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.